PRCT — PROCEPT BioRobotics Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1588978 ·
Last close
$23.78
Market Cap
$1.37B
52W High
$38.11
52W Low
$16.67
ADV30
1,340,599
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 98,291,000 | 65,148,000 | -27,376,000 | -26,516,000 | 473,759,000 | 218,369,000 | 144,851,000 |
| Jun 2026 | 94,498,000 | 62,379,000 | -27,390,000 | -26,861,000 | 479,352,000 | 227,914,000 | 139,282,000 |
| Mar 2026 | 83,132,000 | 53,947,000 | -32,606,000 | -31,638,000 | 487,062,000 | 245,641,000 | 139,395,000 |
| Dec 2025 | 76,383,000 | 46,313,000 | -31,041,000 | -29,845,000 | 508,081,000 | 286,503,000 | 142,211,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-76,690,000
Investing CF
$-8,384,000
Financing CF
$9,257,000
CapEx
$-8,384,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.02
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-726,572,000
Inventory
$81,410,000
Receivables
$105,030,000
ST Investments
—
EBIT TTM
$-111,267,000
Pretax Income TTM
$-114,677,000
Interest Exp TTM
$3,410,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$352,304,992
EBITDA
$-113,640,000
Free Cash Flow
$-44,437,376
Enterprise Value
$1,045,017,792
Total Cash
$218,368,992
Total Debt
$76,992,000
Shares Out
57,536,121
Trailing EPS
$-2.02
Book Value
$5.73
ROE
-32.4%
ROA
-15.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 308,054,000 | -103,859,000 | -95,572,000 | 508,081,000 | 142,211,000 | 365,870,000 | -48,985,000 |
| Dec 2024 | 224,498,000 | -96,614,000 | -91,413,000 | 534,017,000 | 131,797,000 | 402,220,000 | -99,213,000 |
| Dec 2023 | 136,191,000 | -109,170,000 | -105,897,000 | 404,717,000 | 123,965,000 | 280,752,000 | -108,003,000 |
| Dec 2022 | 75,014,000 | -80,724,000 | -87,154,000 | 309,329,000 | 112,257,000 | 197,072,000 | -80,382,000 |
TTM Snapshot
Revenues TTM
$337,340,000
NetIncome TTM
$-109,756,000
OpCashFlow TTM
—
Assets (Latest)
$479,352,000
Forward EPS
$-1.17
Max Pain — expiry 2027-01-15
max pain strike: $15.00 · spot: $25.18 · call oi: 3,103 · put oi: 576
Expected Move to 2027-01-15:
±$5.75
(22.84%) —
implied range
$19.43 –
$30.93
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CDRE | Cadre Holdings, Inc. | $1.39B | $32.41 | — |
| BFLY | Butterfly Network, Inc. | $1.41B | $5.75 | — |
| NVCR | NovoCure Ltd | $1.30B | $11.14 | — |
| CNMD | CONMED Corp | $1.44B | $48.39 | — |
| ENOV | Enovis CORP | $1.57B | $27.22 | — |
News headlines (Yahoo Finance, 1h cache)
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
2026-11-18 21:05 · Yahoo
PROCEPT BioRobotics (PRCT) Stock Looks Overvalued Against Its Sales Story
2026-11-13 20:06 · Yahoo
PROCEPT BioRobotics (PRCT) Stock Dropped, So What Is Driving Attention Now?
2026-11-06 18:19 · Yahoo
PROCEPT BioRobotics Corp (PRCT) (Q3 2026) Earnings Call Highlights: Revenue Grows 18% as Hydros ...
2026-11-05 07:14 · Yahoo
PROCEPT BioRobotics Q3 Earnings Call Highlights
2026-11-05 05:14 · Yahoo
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates
2026-11-04 23:45 · Yahoo
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
2026-11-04 21:05 · Yahoo
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2026-10-28 13:00 · Yahoo
PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow Hopes
2026-10-25 15:07 · Yahoo
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
2026-10-12 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.